Original Article2026
Whole-genome sequencing of 248 Mpox virus isolates from 14 provinces in DRC reveals substantial genetic diversity and identifies novel clades with potential implications for vaccine efficacy.
Short Communication2026
Description of the design and first-year results of the ARBO-SENTINEL network, a multi-country sentinel surveillance system for dengue, chikungunya, yellow fever and Zika viruses in Central Africa.
Meta-Analysis2026
A systematic review and meta-analysis of 87 studies reporting molecular markers of antimalarial drug resistance in P. falciparum from Central Africa, revealing emerging artemisinin partial resistance in western DRC.
Case Report2026
Case report describing a severe Mpox infection with multi-organ involvement in an HIV-positive patient in Kinshasa, highlighting the need for enhanced clinical management protocols in endemic areas.
Original Article2026
A randomized, double-blind, placebo-controlled phase III trial evaluating the efficacy of the Ad26.ZEBOV/MVA-BN-Filo Ebola vaccine regimen among healthcare workers and at-risk populations in the Democratic Republic of the Congo.
Original Article2026
Étude transversale évaluant la prévalence de la résistance aux pyréthrinoïdes chez Anopheles gambiae s.l. dans quatre zones de santé de Kinshasa à l'aide de tests OMS et de caractérisation moléculaire.
Original Article2026
This multicentre randomised phase III trial demonstrates non-inferiority of oral fexinidazole compared to the standard NECT regimen for stage 2 HAT, with a cure rate of 95.2% vs 93.8% at 18 months.